SMTL ID : 6b3w.2 (1 other biounit)

Structure of Hs/AcPRC2 in complex with 5,8-dichloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.05 Å
Oligo State
hetero-1-1-1-mer
Ligands
7 x ZN: ZINC ION(Non-covalent)
1 x CJG: 5,8-dichloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Kung, P.P. et al., Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497). J. Med. Chem. (2018)
Release Date
2017-12-27
Peptides
Enhancer of zeste 2 polycomb repressive complex 2 subunit,Enhancer of zeste 2 polycomb repressive complex 2 subunit: A
Polycomb protein EED: B
Polycomb protein SUZ12: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B
B
E
C
S

Enhancer of zeste 2 polycomb repressive complex 2 subunit,Enhancer of zeste 2 polycomb repressive complex 2 subunit

Polycomb protein EED

Polycomb protein SUZ12

Related Entries With Identical Sequence

4w2r.1 | 4w2r.2 | 5ij7.1 | 5ij7.2 | 5ij8.1 | 5ij8.2 | 6b3w.1